Welcome to LookChem.com Sign In|Join Free

CAS

  • or

875148-45-1

Lexiscan, also known as regadenoson, is a prescription medication that functions as a pharmacologic stress agent for myocardial perfusion imaging. It is specifically designed for patients who cannot exercise adequately. Lexiscan operates by increasing blood flow to the heart, which assists healthcare providers in assessing the presence of coronary artery disease. Administered as an intravenous injection, Lexiscan stimulates adenosine receptors in the body, leading to the dilation of coronary arteries.

875148-45-1 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 875148-45-1 Structure

  • Basic information

    1. Product Name: Lexiscan
    2. Synonyms: Cvt 3146;Lexiscan
    3. CAS NO:875148-45-1
    4. Molecular Formula: C15H20N8O6
    5. Molecular Weight: 408.3693
    6. EINECS: N/A
    7. Product Categories: N/A
    8. Mol File: 875148-45-1.mol

  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: N/A
    3. Flash Point: N/A
    4. Appearance: /
    5. Density: N/A
    6. Refractive Index: N/A
    7. Storage Temp.: N/A
    8. Solubility: N/A
    9. CAS DataBase Reference: Lexiscan(CAS DataBase Reference)
    10. NIST Chemistry Reference: Lexiscan(875148-45-1)
    11. EPA Substance Registry System: Lexiscan(875148-45-1)

  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 875148-45-1(Hazardous Substances Data)

875148-45-1 Usage

Uses

Used in Cardiology:
Lexiscan is used as a diagnostic tool for evaluating the presence of coronary artery disease in patients who are unable to undergo exercise stress testing. It is used for:
1. Myocardial Perfusion Imaging: Lexiscan is used as a pharmacologic stress agent for myocardial perfusion imaging to help healthcare providers detect and diagnose coronary artery disease by increasing blood flow to the heart.
2. Adenosine Receptor Stimulation: Lexiscan is used to stimulate adenosine receptors in the body, which results in the dilation of coronary arteries, providing a clearer view of blood flow and blockages within the heart.
Common side effects associated with Lexiscan may include flushing, chest discomfort, shortness of breath, dizziness, and headache. It is crucial for patients to inform their healthcare providers about any pre-existing heart conditions, asthma, or other lung diseases before receiving Lexiscan treatment.

Check Digit Verification of cas no

The CAS Registry Mumber 875148-45-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,7,5,1,4 and 8 respectively; the second part has 2 digits, 4 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 875148-45:
(8*8)+(7*7)+(6*5)+(5*1)+(4*4)+(3*8)+(2*4)+(1*5)=201
201 % 10 = 1
So 875148-45-1 is a valid CAS Registry Number.

875148-45-1SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 20, 2017

Revision Date: Aug 20, 2017

1.Identification

1.1 GHS Product identifier

Product name 1-[6-amino-9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]purin-2-yl]-N-methylpyrazole-4-carboxamide,hydrate

1.2 Other means of identification

Product number -
Other names CVT 3146

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:875148-45-1 SDS

875148-45-1Downstream Products

875148-45-1Relevant articles and documents

PROCESS FOR PREPARING AN A2A-ADENOSINE RECEPTOR AGONIST AND ITS POLYMORPHS

-

Page/Page column 27-29, (2009/01/20)

Disclosed is a synthesis suitable for large scale manufacture of an A2A-adenosine receptor agonist, and also relates to polymorphs of that compound, and to methods of isolating a specific polymorph.

PROCESS FOR PREPARING AN A2A-ADENOSINE RECEPTOR AGONIST AND ITS POLYMORPHS

-

Page/Page column 25-26, (2008/06/13)

Disclosed is a synthesis suitable for large scale manufacture of an A2A- adenosine receptor agonist, and also relates to polymorphs of that compound, and to methods of isolating a specific polymorph.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 875148-45-1